Verition Fund Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-74,330
| Closed | -$329K | – | 2774 |
|
|
2024
Q4 | $329K | Buy |
74,330
+56,905
| +327% | +$252K | ﹤0.01% | 2101 |
|
|
2024
Q3 | $71.8K | Buy |
+17,425
| New | +$71.8K | ﹤0.01% | 2324 |
|
|
2024
Q2 | – | Sell |
-56,583
| Closed | -$493K | – | 2448 |
|
|
2024
Q1 | $493K | Buy |
+56,583
| New | +$493K | ﹤0.01% | 1469 |
|
|
2023
Q4 | – | Sell |
-72,462
| Closed | -$698K | – | 2050 |
|
|
2023
Q3 | $698K | Buy |
72,462
+38,397
| +113% | +$370K | 0.01% | 1049 |
|
|
2023
Q2 | $362K | Buy |
+34,065
| New | +$362K | ﹤0.01% | 1224 |
|
|
2022
Q3 | – | Sell |
-19,707
| Closed | -$227K | – | 2517 |
|
|
2022
Q2 | $227K | Sell |
19,707
-248,819
| -93% | -$2.87M | ﹤0.01% | 1794 |
|
|
2022
Q1 | $3.38M | Sell |
268,526
-127,879
| -32% | -$1.61M | 0.04% | 429 |
|
|
2021
Q4 | $4.62M | Buy |
396,405
+345,912
| +685% | +$4.03M | 0.03% | 286 |
|
|
2021
Q3 | $659K | Sell |
50,493
-12,784
| -20% | -$167K | 0.01% | 868 |
|
|
2021
Q2 | $815K | Buy |
+63,277
| New | +$815K | 0.01% | 776 |
|
|
2021
Q1 | – | Sell |
-41,815
| Closed | -$476K | – | 1520 |
|
|
2020
Q4 | $476K | Buy |
41,815
+27,894
| +200% | +$318K | ﹤0.01% | 575 |
|
|
2020
Q3 | $125K | Buy |
+13,921
| New | +$125K | ﹤0.01% | 892 |
|
|
2020
Q1 | – | Sell |
-11,044
| Closed | -$147K | – | 728 |
|
|
2019
Q4 | $147K | Buy |
+11,044
| New | +$147K | ﹤0.01% | 875 |
|
|
2019
Q2 | – | Sell |
-13,854
| Closed | -$157K | – | 1105 |
|
|
2019
Q1 | $157K | Buy |
+13,854
| New | +$157K | 0.01% | 923 |
|